Knight Therapeutics Inc. (GUD.TO) TSX

5.90

-0.01(-0.17%)

Updated at January 14 01:27PM

Currency In CAD

Valuation

Market Cap539.56M
Enterprise Value508.91M
P/E Ratio-170.04
PEG Ratio0.12
Price/Sales Ratio1.44
Price/Book Ratio0.77
Enterprise/Revenue1.5
Enterprise/EBITDA11.4

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.01
Operating Margin-0.03

Management Effectiveness

Return On Assets-0
Return On Equity-0

Income Statement

Revenue371.3M
Revenue/Share4.15
Gross Profit174.41M
EBITDA64.38M
Net Income4.33M
Diluted EPS0.04

Balance Sheet

Total Cash95.56M
Total Cash/Share0.96
Total Debt106.24M
Total Debt/Equity0.14
Current Ratio2.62
Book Value Per Share7.69

Price History

52-Week Change12.45
52-Week High6.55
52-Week Low5.26
Moving Average 50 Days6.02
Moving Average 200 Days6.02

Statistics

Average Volume46,809
Shares Outstanding99.87M
% Held by Institutions0.13

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A